A red circle is inscribed inside a blue square. The arrangement leaves gaps in the square’s four corners, two of which are filled with smaller circles that just barely touch the big red circle and the ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

Some situations in life are zero-sum. On Super Bowl Sunday, two teams take the field but only one will emerge victorious, Vince Lombardi Trophy in hand. In a presidential election, only one candidate ...

Abstract: Many applications in automated auditing and the analysis and consistency check of financial documents can be formulated in part as the subset sum problem: Given a set of numbers and a target ...

The ARAQYS-D3 mission by Dcubed will demonstrate the ability to manufacture a solar array 15 meters long in orbit. Credit: Dcubed BREMEN, Germany — German satellite component company Dcubed is moving ...

Telisotuzumab adizutecan (ABBV-400; Temab-A), a c-Met protein–targeting antibody-drug conjugate (ADC), in patients (pts) with advanced EGFR-mutated (MT) non-squamous (NSQ) non-small cell lung cancer ...

Every video game is a miracle. Long hours, extraordinary technical and artistic requirements and cross-disciplinary collaboration: the very act of making games is difficult, and leaves room for ...

It's official: The Gulf of Mexico is no more (at least in the United States). Employees at the federal Board on Geographic Names have formally changed the name to the Gulf of America per one of ...

The latest State of JavaScript survey provides an up-close look at the JavaScript language features, tools, libraries, and frameworks developers are using and how they're using them. Getting a ...

Ergo Sum is an Exotic sword in Destiny 2, added in The Final Shape expansion. This is not only the sword you saw on your grave back in the Corridors of Time — giving it some major lore significance — ...

A phase I monotherapy dose escalation study of HFB301001, a novel next generation OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors. This is an ASCO Meeting Abstract from ...